Stoke Therapeutics, Inc. (STOK) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 6.23M | 1.4M | 10.63M | 13.82M | 158.57M | 22.61M | 4.89M | 4.83M | 4.22M | 2.8M | 3.31M | -2.48M | 5.15M | 3.27M | 2.9M | 3.23M | 3M | 0 | 0 | 0 |
| Revenue Growth % | -96.07% | -93.8% | 117.25% | 186.01% | 3661.12% | 707.07% | 47.94% | 294.72% | -18.17% | -14.29% | 13.87% | -176.79% | 71.73% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1.05M | 1.05M | 989K | 0 | 0 | 0 | 0 | 1.11M | 1.11M | 1.22M | 1.2M | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | 0 | 0 | 0 |
| COGS % of Revenue | 16.81% | 75.25% | 9.3% | - | - | - | - | 22.98% | 26.4% | 43.36% | 36.28% | -47.04% | 22.26% | 35.24% | 31.81% | 25.84% | 20.8% | - | - | - |
| Gross Profit | 5.18M | 347K | 9.64M | 13.82M | 158.57M | 22.61M | 4.89M | 3.72M | 3.1M | 1.59M | 2.11M | -3.65M | 4M | 2.12M | 1.98M | 2.4M | 2.38M | 0 | 0 | 0 |
| Gross Margin % | 83.19% | 24.75% | 90.7% | 100% | 100% | 100% | 100% | 77.02% | 73.6% | 56.64% | 63.72% | 147.04% | 77.74% | 64.76% | 68.19% | 74.16% | 79.2% | - | - | - |
| Gross Profit Growth % | -96.73% | -98.47% | 97.04% | 271.32% | 5010.18% | 1324.95% | 132.16% | 202% | -22.52% | -25.04% | 6.41% | -252.25% | 68.56% | - | - | - | - | - | - | - |
| Operating Expenses | 58.6M | 61.79M | 52.73M | 41.12M | 47.33M | 36.27M | 34.9M | 33.06M | 31.48M | 31.17M | 29.34M | 29.61M | 28.7M | 29.29M | 29.13M | 27.63M | 27.17M | 24.53M | 22.68M | 22.03M |
| OpEx % of Revenue | 940.76% | 4406.99% | 495.99% | 297.58% | 29.85% | 160.37% | 713.06% | 684.39% | 746.56% | 1112.53% | 887% | -1193.63% | 556.97% | 896.05% | 1002.72% | 855.28% | 905.7% | - | - | - |
| Selling, General & Admin | 19.97M | 20.5M | 15.48M | 15.26M | 14.65M | 12.84M | 12.69M | 12.47M | 9.67M | 10.02M | 9.71M | 9.67M | 9.66M | 8.84M | 9.41M | 9.58M | 9.11M | 8.72M | 8.32M | 7.93M |
| SG&A % of Revenue | 320.66% | 1461.91% | 145.6% | 110.46% | 9.24% | 56.8% | 259.34% | 258.23% | 229.36% | 357.57% | 293.47% | -389.92% | 187.52% | 270.42% | 323.86% | 296.44% | 303.63% | - | - | - |
| Research & Development | 39.67M | 41.29M | 37.25M | 25.86M | 32.68M | 23.42M | 22.2M | 20.59M | 21.8M | 21.15M | 19.63M | 19.94M | 19.03M | 20.45M | 19.72M | 18.06M | 18.06M | 15.8M | 14.36M | 14.1M |
| R&D % of Revenue | 636.91% | 2945.08% | 350.4% | 187.12% | 20.61% | 103.58% | 453.72% | 426.16% | 517.2% | 754.96% | 593.53% | -803.71% | 369.45% | 625.63% | 678.86% | 558.84% | 602.07% | - | - | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -53.42M | -61.44M | -43.09M | -27.3M | 111.24M | -13.65M | -30M | -29.34M | -28.37M | -29.59M | -27.23M | -33.26M | -24.69M | -27.18M | -27.15M | -25.24M | -24.8M | -24.53M | -22.68M | -22.03M |
| Operating Margin % | -857.57% | -4382.24% | -405.3% | -197.58% | 70.15% | -60.37% | -613.06% | -607.37% | -672.96% | -1055.89% | -823.28% | 1340.67% | -479.23% | -831.29% | -934.53% | -781.12% | -826.5% | - | - | - |
| Operating Income Growth % | -148.02% | -350% | -43.62% | 6.96% | 492.08% | 53.85% | -10.17% | 11.79% | -14.91% | -8.87% | -0.32% | -31.79% | 0.42% | -10.8% | -19.68% | -14.57% | -47.35% | -68.15% | -65.44% | -69.3% |
| EBITDA | -52.37M | -60.38M | -42.1M | -26.85M | 111.72M | -13.13M | -29.46M | -28.79M | -27.81M | -28.96M | -26.03M | -32.09M | -23.54M | -26.02M | -26.22M | -24.4M | -24.17M | -24.29M | -22.43M | -21.78M |
| EBITDA Margin % | -840.76% | -4306.99% | -395.99% | -194.35% | 70.45% | -58.05% | -602.02% | -596.03% | -659.61% | -1033.62% | -787% | 1293.63% | -456.97% | -796.05% | -902.72% | -755.28% | -805.7% | - | - | - |
| EBITDA Growth % | -146.88% | -360% | -42.9% | 6.74% | 501.73% | 54.68% | -13.17% | 10.29% | -18.12% | -11.29% | 0.72% | -31.52% | 2.6% | -7.13% | -16.92% | -12.04% | -45.69% | -69.29% | -66.42% | -70.32% |
| D&A (Non-Cash Add-back) | 1.05M | 1.05M | 989K | 446K | 477K | 526K | 540K | 548K | 563K | 624K | 1.2M | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | 235K | 254K | 249K |
| EBIT | -53.42M | -61.44M | -39.62M | -27.3M | 111.24M | -13.65M | -30M | -29.34M | -28.37M | -29.59M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.53M | -22.68M | -22.03M |
| Net Interest Income | -3.4M | 3.62M | 3.46M | 0 | 0 | 0 | 0 | 3.69M | 2.43M | 2.59M | 2.65M | 2.57M | 2.1M | 1.48M | 995K | 544K | 104K | 36K | 44K | 34K |
| Interest Income | 0 | 3.62M | 3.47M | 0 | 0 | 0 | 0 | 3.69M | 2.43M | 2.59M | 2.65M | 2.57M | 2.1M | 1.48M | 995K | 544K | 104K | 36K | 44K | 34K |
| Interest Expense | 3.4M | 3K | 3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Other Income/Expense | 3.42M | 3.5M | 3.47M | 3.82M | 2.92M | 3.17M | 3.57M | 3.65M | 2M | 2.63M | 2.69M | 2.61M | 2.15M | 1.52M | 1.04M | 586K | 146K | 78K | 86K | 62K |
| Pretax Income | -50M | -57.93M | -39.63M | -23.48M | 114.16M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M |
| Pretax Margin % | -802.75% | -4132.24% | -372.7% | -169.96% | 71.99% | -46.35% | -540.05% | -531.88% | -625.57% | -962.1% | -741.9% | 1235.55% | -437.6% | -784.8% | -898.83% | -762.98% | -821.63% | - | - | - |
| Income Tax | 0 | 0 | -1.28M | 0 | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 3.23% | 0% | 1.12% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -50M | -57.93M | -38.35M | -23.48M | 112.88M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M |
| Net Margin % | -802.75% | -4132.24% | -360.68% | -169.96% | 71.19% | -46.35% | -540.05% | -531.88% | -625.57% | -962.1% | -741.9% | 1235.55% | -437.6% | -784.8% | -898.83% | -762.98% | -821.63% | - | - | - |
| Net Income Growth % | -144.3% | -452.7% | -45.09% | 8.61% | 527.99% | 61.12% | -7.69% | 16.18% | -16.98% | -5.08% | 6.01% | -24.35% | 8.54% | -4.94% | -15.55% | -12.22% | -46.78% | -67.9% | -65.13% | -69.51% |
| Net Income (Continuing) | -50M | -57.93M | -38.35M | -23.48M | 112.88M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.79 | -0.99 | -0.65 | -0.40 | 1.90 | -0.18 | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.60 |
| EPS Growth % | -141.58% | -450% | -38.3% | 13.04% | 433.33% | 70% | 14.55% | 33.33% | -32.56% | -7.14% | 9.84% | -16.95% | 33.85% | 15.15% | 0% | 1.67% | -41.3% | -57.14% | -48.78% | -53.85% |
| EPS (Basic) | -0.79 | -0.99 | -0.65 | -0.40 | 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.60 |
| Diluted Shares Outstanding | 63.06M | 58.39M | 58.61M | 58.35M | 59.4M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M |
| Basic Shares Outstanding | 63.06M | 58.39M | 58.61M | 58.35M | 57.86M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |